Effect of antihypertensive therapy on cognitive function in early executive cognitive impairment: a double-blind randomized clinical trial.
作者信息
Hajjar Ihab, Hart Meaghan, Chen Yu-Ling, Mack Wendy, Milberg William, Chui Helena, Lipsitz Lewis
出版信息
Arch Intern Med. 2012 Mar 12;172(5):442-4. doi: 10.1001/archinternmed.2011.1391.
Abstract
摘要
相似文献
1
Effect of antihypertensive therapy on cognitive function in early executive cognitive impairment: a double-blind randomized clinical trial.
Arch Intern Med. 2012 Mar 12;172(5):442-4. doi: 10.1001/archinternmed.2011.1391.
2
Do angiotensin receptor blockers really hold promise for the improvement of cognitive functioning?
Arch Intern Med. 2012 Aug 13;172(15):1191-2; author reply 1192. doi: 10.1001/archinternmed.2012.2091.
3
Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, randomized clinical trial.
J Hum Hypertens. 2005 Jun;19(6):429-37. doi: 10.1038/sj.jhh.1001812.
4
The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.
J Hypertens. 2003 May;21(5):875-86. doi: 10.1097/00004872-200305000-00011.
5
Antihypertensive therapy and cerebral hemodynamics in executive mild cognitive impairment: results of a pilot randomized clinical trial.
J Am Geriatr Soc. 2013 Feb;61(2):194-201. doi: 10.1111/jgs.12100. Epub 2013 Jan 25.
6
Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients.
J Hum Hypertens. 2006 Mar;20(3):177-85. doi: 10.1038/sj.jhh.1001964.
7
Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults With Executive Mild Cognitive Impairment: A Randomized Clinical Trial.
JAMA Netw Open. 2020 Aug 3;3(8):e2012252. doi: 10.1001/jamanetworkopen.2020.12252.
8
Comparison of the AT1-receptor blocker, candesartan cilexetil, and the ACE inhibitor, lisinopril, in fixed combination with low dose hydrochlorothiazide in hypertensive patients.
J Hum Hypertens. 2000 Apr;14(4):263-9. doi: 10.1038/sj.jhh.1000997.
9
Combination therapy with candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg provides the full additive antihypertensive effect of the components: A randomized, double-blind, parallel-group study in primary care.
Clin Drug Investig. 2009;29(5):293-304. doi: 10.2165/00044011-200929050-00002.
10
Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.
Clin Ther. 2001 Jun;23(6):833-50. doi: 10.1016/s0149-2918(01)80072-2.
引用本文的文献
1
The application of telmisartan in central nervous system disorders.
Pharmacol Rep. 2025 Jun 19. doi: 10.1007/s43440-025-00737-2.
2
Therapeutic Implications of Renin-Angiotensin System Modulators in Alzheimer's Dementia.
Pharmaceutics. 2023 Sep 6;15(9):2290. doi: 10.3390/pharmaceutics15092290.
3
First-line diuretics versus other classes of antihypertensive drugs for hypertension.
Cochrane Database Syst Rev. 2023 Jul 13;7(7):CD008161. doi: 10.1002/14651858.CD008161.pub3.
4
Deciphering mechanisms of action of ACE inhibitors in neurodegeneration using models of Alzheimer's disease.
Front Neurosci. 2023 Apr 11;17:1166973. doi: 10.3389/fnins.2023.1166973. eCollection 2023.
5
Safety and biomarker effects of candesartan in non-hypertensive adults with prodromal Alzheimer's disease.
Brain Commun. 2022 Oct 25;4(6):fcac270. doi: 10.1093/braincomms/fcac270. eCollection 2022.
6
RENEWAL: REpurposing study to find NEW compounds with Activity for Lewy body dementia-an international Delphi consensus.
Alzheimers Res Ther. 2022 Nov 11;14(1):169. doi: 10.1186/s13195-022-01103-7.
7
Cognitive Impairment in Heart Failure: Landscape, Challenges, and Future Directions.
Front Cardiovasc Med. 2022 Feb 7;8:831734. doi: 10.3389/fcvm.2021.831734. eCollection 2021.
8
Simvastatin therapy attenuates memory deficits that associate with brain monocyte infiltration in chronic hypercholesterolemia.
NPJ Aging Mech Dis. 2021 Aug 4;7(1):19. doi: 10.1038/s41514-021-00071-w.
9
Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementia.
Cochrane Database Syst Rev. 2021 May 24;5(5):CD004034. doi: 10.1002/14651858.CD004034.pub4.
10
Brain Renin-Angiotensin System at the Intersect of Physical and Cognitive Frailty.
Front Neurosci. 2020 Sep 30;14:586314. doi: 10.3389/fnins.2020.586314. eCollection 2020.
本文引用的文献
1
In situ monitoring of health in older adults: technologies and issues.
J Am Geriatr Soc. 2010 Aug;58(8):1579-86. doi: 10.1111/j.1532-5415.2010.02959.x. Epub 2010 Jul 14.
2
Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB.
Hypertension. 2010 Apr;55(4):924-31. doi: 10.1161/HYPERTENSIONAHA.109.147843. Epub 2010 Feb 15.
3
Hypertension, executive dysfunction, and progression to dementia: the canadian study of health and aging.
Arch Neurol. 2010 Feb;67(2):187-92. doi: 10.1001/archneurol.2009.312.
4
The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment: role of the renin angiotensin system inhibition.
BMC Geriatr. 2009 Nov 18;9:48. doi: 10.1186/1471-2318-9-48.
5
Brain renin-angiotensin system in cognitive function: pre-clinical findings and implications for prevention and treatment of dementia.
Acta Neurol Belg. 2009 Sep;109(3):171-80.
6
The angiotensin II type 2 receptor in the brain.
J Renin Angiotensin Aldosterone Syst. 2010 Mar;11(1):1-6. doi: 10.1177/1470320309347793. Epub 2009 Oct 27.
7
Prevalence of disorders of executive cognitive functioning among the elderly: findings from the San Luis Valley Health and Aging Study.
Neuroepidemiology. 2002 Sep-Oct;21(5):213-20. doi: 10.1159/000065638.
8
Effect of the angiotensin II type 1 receptor blocker candesartan on endothelial function in patients with essential hypertension.
Hypertension. 2000 Jan;35(1 Pt 2):501-6. doi: 10.1161/01.hyp.35.1.501.
Zotero 插件